Joint Society of Urologic Oncology (SUO)/EAU Section of Oncological Urology (ESOU) Symposium: Multimodality Approach to GU Cancers

Saturday, November 14, 2026

11:15 - 12:45 CET

Co-Chair(s)

Alessandro Volpe

Urologist
University of Eastern Piedmont, Maggiore della Carità Hospital, Italy
Badrinath Konety

President and Chief Academic Officer
Allina Health Cancer Institute, Allina Health System, United States

11:15 CET

Prostate Cancer
11:15 - 11:25 CET

Role Of Neoadjuvant Therapy Prior To Prostatectomy in High Risk Prostate Cancer
Speaker: Adam Kibel
11:25 - 11:45 CET

Clinical Case Discussion on Use of Genomic Markers and AI in Driving Decision Making in Prostate Cancer
Moderator: Juan Gomez Rivas – Hospital Clínico San Carlos. Madrid
Panelist: Adam Kibel
11:45 CET

Bladder Cancer
11:45 - 11:55 CET

Is There Still a Role for Cystectomy After Neoadjuvant Therapy in MIBC?
Speaker: Badrinath Konety – Allina Health Cancer Institute, Allina Health System
11:55 - 12:15 CET

Clinical Case Discussion on Sequencing of Newer Agents in NMIBC
Moderator: Marco Moschini
Panelist: Badrinath Konety – Allina Health Cancer Institute, Allina Health System
Panelist: Seth Lerner – Baylor College of Medicine
12:15 CET

Renal Cell Carcinoma (RCC)
12:15 - 12:25 CET

Clinical Case Discussion on Management of Locally Advanced and Oligometastatic RCC
Panelist: Barbara Jereczek – University of Milan and European Institute of Oncology IRCCS Milan Italy
Panelist: Simon Tanguay – McGill University
Panelist: Alessandro Volpe – University of Eastern Piedmont, Maggiore della Carità Hospital
12:25 - 12:45 CET

Adjuvant Therapy in High-Risk Non Metastatic RCC: for Some or for Everyone?
Speaker: Alessandro Volpe – University of Eastern Piedmont, Maggiore della Carità Hospital